SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-22-008103
Filing Date
2022-05-10
Accepted
2022-05-10 16:15:02
Documents
62
Period of Report
2022-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q rphm-20220331x10q.htm   iXBRL 10-Q 1604141
2 EX-31.1 rphm-20220331xex31d1.htm EX-31.1 15780
3 EX-31.2 rphm-20220331xex31d2.htm EX-31.2 15397
4 EX-32.1 rphm-20220331xex32d1.htm EX-32.1 9096
5 EX-32.2 rphm-20220331xex32d2.htm EX-32.2 7882
6 GRAPHIC rphm-20220331x10q004.jpg GRAPHIC 8922
  Complete submission text file 0001558370-22-008103.txt   5493845

Data Files

Seq Description Document Type Size
7 EX-101.SCH rphm-20220331.xsd EX-101.SCH 37532
8 EX-101.CAL rphm-20220331_cal.xml EX-101.CAL 36912
9 EX-101.DEF rphm-20220331_def.xml EX-101.DEF 178257
10 EX-101.LAB rphm-20220331_lab.xml EX-101.LAB 355027
11 EX-101.PRE rphm-20220331_pre.xml EX-101.PRE 287614
56 EXTRACTED XBRL INSTANCE DOCUMENT rphm-20220331x10q_htm.xml XML 715390
Mailing Address 18575 JAMBOREE ROAD SUITE 275-S IRVINE CA 92612
Business Address 18575 JAMBOREE ROAD SUITE 275-S IRVINE CA 92612 (858) 283-0280
Reneo Pharmaceuticals, Inc. (Filer) CIK: 0001637715 (see all company filings)

IRS No.: 472309515 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-40315 | Film No.: 22909783
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences